Recent developments in health and medicine highlight advancements in screening tools, drug safety alerts, and environmental sustainability in clinical settings.

A study indicates that individuals with higher psychological resilience years before death experience a significantly lower burden of pain, depression, and fatigue at the end of life.

The MHRA has suspended the use of the drug avacopan following the discovery of serious irregularities in pivotal trial data, despite anecdotal evidence of its clinical efficacy.

Research reveals that the carbon footprint of anesthesia in cesarean deliveries is largely driven by the high volume of disposable items that are opened but discarded without being used.

Clinicians now have access to a new 25-minute diagnostic tool designed to evaluate over 30 potential factors contributing to obesity, ranging from genetic predispositions to psychological trauma.

Post-marketing surveillance has confirmed that the safety profile of sofpironium gel, used for treating excessive axillary sweating, remains consistent with findings from initial clinical trials.

New findings suggest that prenatal exposure to certain antiseizure medications increases the risk of infants being born with lower birth weights or smaller sizes for gestational age.

Health officials in the UK are monitoring east London after the first-ever discovery of invasive mosquito populations breeding in the country, noting that current public health risks remain low.

Patients treated with lipid-lowering drugs have been found to have double the risk of experiencing severe anaphylaxis following a Hymenoptera sting compared to those not on such medication.